bromodeoxyuridine has been researched along with thiotepa in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (62.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hansch, C; Khwaja, TA; Selassie, CD | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Hofstadter, F; Jenkins, WE; Knuchel, R; Masters, JR | 1 |
| Dozi-Vassiliades, J; Hatzitheodoridou, P; Koliouskas, DE; Kourakis, A; Mourelatos, D | 1 |
| Hoshino, T; Wilson, CB | 1 |
| Bochkov, NP; Chebotarev, AN; Platonova, VI | 1 |
| Chebotarev, AN; Listopad, GG | 1 |
| Gulinello, ME; Mondie, CM; Vandergrift, KA; Weber, ET; Wilson, CL | 1 |
8 other study(ies) available for bromodeoxyuridine and thiotepa
| Article | Year |
|---|---|
Structure-activity relationships of antineoplastic agents in multidrug resistance.
Topics: Animals; Antineoplastic Agents; Cell Line; Cell Survival; Cricetinae; Dactinomycin; Drug Resistance; Leukemia L1210; Mice; Regression Analysis; Structure-Activity Relationship; Tumor Cells, Cultured | 1990 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Sensitivities of monolayers and spheroids of the human bladder cancer cell line MGH-U1 to the drugs used for intravesical chemotherapy.
Topics: Administration, Topical; Bromodeoxyuridine; Carcinoma, Transitional Cell; Cell Survival; DNA, Neoplasm; Doxorubicin; Drug Screening Assays, Antitumor; Humans; Thiotepa; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1989 |
Enhancement of cytogenetic damage by inhibitors of poly(ADP-ribose)polymerase in human lymphocytes exposed to antineoplastics in vivo and in vitro.
Topics: Benzamides; Bromodeoxyuridine; Cell Division; Colchicine; Drug Synergism; Humans; Kinetics; Lymphocytes; Melphalan; Mutagens; Poly(ADP-ribose) Polymerase Inhibitors; Sister Chromatid Exchange; Thiotepa | 1986 |
Current trends in the chemotherapy of brain tumors with special reference to glioblastomas.
Topics: Alkaloids; Antibiotics, Antineoplastic; Antineoplastic Agents; Azaguanine; Blood Vessel Prosthesis; Blood-Brain Barrier; Brain; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Cell Transformation, Neoplastic; Disease Models, Animal; Fluorouracil; Glioblastoma; Humans; Injections, Intra-Arterial; Injections, Spinal; Mechlorethamine; Methotrexate; Nitroso Compounds; Thiotepa; Time Factors; Urea; Vincristine | 1969 |
[Dynamics of the frequencies of chemically induced sister chromatid exchanges in a series of cell generations].
Topics: Alkylating Agents; Animals; Aziridines; Bromodeoxyuridine; Cells, Cultured; Cricetinae; Cricetulus; Crossing Over, Genetic; Humans; Lymphocytes; Mitogens; Sister Chromatid Exchange; Thiotepa; Time Factors | 1983 |
[Effect of the duration of 5-bromodeoxyuridine on the number sister chromatid exchanges in human cells].
Topics: Bromodeoxyuridine; Cells, Cultured; Crossing Over, Genetic; Humans; Lymphocytes; Sister Chromatid Exchange; Stimulation, Chemical; Thiotepa | 1980 |
The chemotherapy agent, thioTEPA, yields long-term impairment of hippocampal cell proliferation and memory deficits but not depression-related behaviors in mice.
Topics: Analysis of Variance; Animals; Antineoplastic Agents, Alkylating; Behavior, Animal; Bromodeoxyuridine; Cell Proliferation; Cell Survival; Conditioning, Operant; Depression; Disease Models, Animal; Hippocampus; Male; Memory Disorders; Mice; Mice, Inbred C57BL; Recognition, Psychology; Thiotepa; Time Factors | 2010 |